Form 3CL, Download Income Tax Form 3CL in PDF Format

FORM NO. 3CL for Report to the Director General (Income-tax Exemptions) under section 35(2AB) of the Income-tax Act, 1961. FORM NO. 3CL is to be submitted by the secretary, Department of Scientific and Industrial research, Government of India, in relation to approval of the in-house research and development facility under section 35(2AB)(4) In order to entitle the assessee to weighted deduction.

Where a company engaged in the business of [bio-technology or in [any business of manufacture or production of any article or thing, not being an article or thing specified in the list of the Eleventh Schedule]] incurs any expenditure on scientific research (not being expenditure in the nature of cost of any land or building) on in-house research and development facility as approved by the prescribed authority, then, there shall be allowed a deduction of [a sum equal to [two] times of the expenditure] so incurred.

[Explanation.—For the purposes of this clause, “expenditure on scientific research”, in relation to drugs and pharmaceuticals, shall include expenditure incurred on clinical drug trial, obtaining approval from any regulatory authority under any Central, State or Provincial Act and filing an application for a patent under the Patents Act, 1970 (39 of 1970)

(2) No deduction shall be allowed in respect of the expenditure mentioned in clause (1) under any other provision of this Act.

(3) No company shall be entitled for deduction under clause (1) unless it enters into an agreement with the prescribed authority for co-operation in such research and development facility and for audit of the accounts maintained for that facility.

(4) The prescribed authority shall submit its report in relation to the approval of the said facility to the Director General in such form and within such time as may be prescribed.]

[(5) No deduction shall be allowed in respect of the expenditure referred to in clause (1) which is incurred after the 31st day of March, [2012].

[(6) No deduction shall be allowed to a company approved under sub-clause (C) of clause (iia) of sub-section (1) in respect of the expenditure referred to in clause (1) which is incurred after the 31st day of March, 2008.]

[(2B)(a) Where [, before the 1st day of March, 1984,] an assessee has incurred any expenditure (not being in the nature of capital expenditure incurred on the acquisition of any land or building or construction of any building) on scientific research undertaken under a programme approved in this behalf by the prescribed authority having regard to the social, economic and industrial needs of India, he shall, subject to the provisions of this sub-section, be allowed a deduction of a sum equal to one and one-fourth times the amount of the expenditure certified by the prescribed authority to have been so incurred during the previous year.

(b) Where a deduction has been allowed under clause (a) for any previous year in respect of any expenditure, no deduction in respect of such expenditure shall be allowed under clause (i) of sub-section (1) or clause (ia) of sub-section (2) for the same or any other previous year.

(c) Where a deduction is allowed for any previous year under this sub-section in respect of expenditure represented wholly or partly by an asset, no deduction shall be allowed in respect of that asset under [clause (ii) of sub-section (1)] of section 32 for the same or any subsequent previous year.

(d) Any deduction made under this sub-section in respect of any expenditure on scientific research in excess of the expenditure actually incurred shall be deemed to have been wrongly made for the purposes of this Act if the assessee fails to furnish within one year of the period allowed by the prescribed authority for completion of the programme, a certificate of its completion obtained from that authority, and the provisions of sub-section (5B) of section 155 shall apply accordingly.

[(3) If any question arises under this section as to whether, and if so, to what extent, any activity constitutes or constituted, or any asset is or was being used for, scientific research, the Board shall refer the question to—

(a)  the Central Government, when such question relates to any activity under clauses (ii) and (iii) of sub-section (1), and its decision shall be final;

(b)  the prescribed authority, when such question relates to any activity other than the activity specified in clause (a), whose decision shall be final.]

(4) The provisions of sub-section (2) of section 32 shall apply in relation to deductions allowable under clause (iv) of sub-section (1) as they apply in relation to deductions allowable in respect of depreciation.

[(5) Where, in a scheme of amalgamation, the amalgamating company sells or otherwise transfers to the amalgamated company (being an Indian company) any asset representing expenditure of a capital nature on scientific research,—

 (i)  the amalgamating company shall not be allowed the deduction under clause (ii) or clause (iii) of sub-section (2); and

(ii)  the provisions of this section shall, as far as may be, apply to the amalgamated company as they would have applied to the amalgamating company if the latter had not so sold or otherwise transferred the asset.


FORM NO. 3CL

Report to be submitted by the prescribed authority to the Director General (Income-tax Exemptions) under section 35(2AB) of the Income-tax Act, 1961

1. Name and Address of the registered office of the company including Telex/Fax/Phone numbers

 

2. Permanent Account Number (PAN) of the company

 


Name and designation of the Principal Officer of the company

 

3. Nature and Business/activity of the company

 

Manufacture/production of-

Drugs

Pharmaceuticals

Electronic Equipments

Computers

Telecommunication Equipments

Chemicals

Any other article or thing notified under sub-section (2AB) of section 35 (please specify)

 

4. Annual production of the eligible products of the company during the past three years.

 

5. Proposed objectives of scientific research contemplated by the company.

 

6. Whether the nature of the business is related to the proposed objectives of the scientific research contemplated by the company.

 

7. Details of the nature of existing in-house Research and Development facilities specifying whether the in-house Research and Development facility is adequate for carrying out scientific research.

 

8. Whether recognition granted to the in-house Research and Development centre of the company by Department of Scientific and Industrial Research.

 

9.

Total cost of in-house research facility, giving break-up of expenditure on land and buildings. (ASSESSMENT YEAR________)

 

10.

Whether agreement for co-operation and Research and Development facility and for audit of the accounts maintained for that facility entered into.

 

Certified that the above information is true to the best of our knowledge and belief.

Place

Date

Signature of Secretary, DSIR

 

 

 

 

 

 

 

This movie requires Flash Player 9

 

Leave a Reply

Your email address will not be published. Required fields are marked *